Could a light helmet ease lewy body dementia?

NCT ID NCT07602296

Not yet recruiting Symptom relief Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special helmet that shines near-infrared light on the brain (called transcranial photobiomodulation) in 40 people with Lewy body dementia. Participants use the helmet twice daily for 6 months. Researchers will check thinking skills, symptoms, and quality of life before and after treatment. The goal is to see if this light therapy can help with memory, attention, and daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LUCIOLE Cap (a non-invasive helmet that shines near-infrared light on the brain)
What this could lead to: If it works, this could point toward a non-drug way to ease thinking and daily-life problems in Lewy body dementia.
What could go wrong: This is a very early, small trial (40 people) testing a device that has never been used in humans before. It may not work or could cause unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Lewy body dementia Lewy Body Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEMENTIA WITH LEWY BODIES LEWY BODIES DISEASE PHOTOBIOMODULATION

Contacts and locations

Locations

Hôpitaux Universitaires de Strasbourg

Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.